Difference between revisions of "Part:BBa K2382007"
Herlohuang (Talk | contribs) (→References) |
Herlohuang (Talk | contribs) (→Usage and Biology) |
||
Line 14: | Line 14: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | And we add a start coden (ATG) | ||
+ | This is the single chain variable fragment (scFv) of an antibody that have ability of binding | ||
+ | aflatoxin. This part basically shares the same sequence with BBa_K2382011, except for a start | ||
+ | codon ATG at the beginning. | ||
+ | |||
Since bacteria can’t produce the whole antibody, we decide to use scFv to | Since bacteria can’t produce the whole antibody, we decide to use scFv to | ||
− | replace it. It contains two polypeptide chains linked by a linker. | + | replace it. It contains two polypeptide chains linked by a linker. |
===Characterization of the Anti-aflatoxin scFv (with start coden)=== | ===Characterization of the Anti-aflatoxin scFv (with start coden)=== |
Revision as of 03:48, 30 October 2017
Anti-aflatoxin scFv (with start coden)
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 342
Illegal SapI.rc site found at 255
Usage and Biology
And we add a start coden (ATG) This is the single chain variable fragment (scFv) of an antibody that have ability of binding aflatoxin. This part basically shares the same sequence with BBa_K2382011, except for a start codon ATG at the beginning.
Since bacteria can’t produce the whole antibody, we decide to use scFv to replace it. It contains two polypeptide chains linked by a linker.
Characterization of the Anti-aflatoxin scFv (with start coden)
References
(1) Li, X., et al., Molecular characterization of monoclonal antibodies against aflatoxins: a possible explanation for the highest sensitivity. Anal Chem, 2012. 84(12): p. 5229-35.
(2) Chen, X., Zaro, J. L., & Shen, W. (2013). Fusion protein linkers: Property, design and functionality. Advanced Drug Delivery Reviews, 65(10), 1357-1369. doi:10.1016/j.addr.2012.09.039